Literature DB >> 29933523

Generating Germ-Free Drosophila to Study Gut-Microbe Interactions: Protocol to Rear Drosophila Under Axenic Conditions.

Christa Kietz1, Vilma Pollari1, Annika Meinander1.   

Abstract

As several diseases have been linked to dysbiosis of the human intestinal microflora, manipulation of the microbiota has emerged as an exciting new strategy for potentially treating and preventing diseases. However, the human microbiota consists of a plethora of different species, and distinguishing the impact of a specific bacterial species on human health is challenging. In tackling this challenge, the fruit fly Drosophila melanogaster, with its far simpler microbial composition, has emerged as a powerful model for unraveling host-microbe interactions. To study the interplay between the resident commensal microbiome and the host, flies can be made germ-free, or axenic. To elucidate the impact of specific bacteria, axenic flies can then be re-introduced to specific microbial species. In this unit, we provide a step-by-step protocol on how to rear Drosophila melanogaster under axenic conditions and confirm the axenity of flies.
© 2018 by John Wiley & Sons, Inc. © 2018 John Wiley & Sons, Inc.

Entities:  

Keywords:  Drosophila melanogaster; axenic; bacteria; commensal; microbiota

Year:  2018        PMID: 29933523     DOI: 10.1002/cptx.52

Source DB:  PubMed          Journal:  Curr Protoc Toxicol        ISSN: 1934-9254


  10 in total

Review 1.  Ecological and evolutionary mechanisms underlying patterns of phylosymbiosis in host-associated microbial communities.

Authors:  Kevin D Kohl
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-03-23       Impact factor: 6.237

Review 2.  The use of non-rodent model species in microbiota studies.

Authors:  Aaron C Ericsson
Journal:  Lab Anim       Date:  2019-06       Impact factor: 2.471

Review 3.  Drosophila as a model to explore secondary injury cascades after traumatic brain injury.

Authors:  Lori M Buhlman; Gokul Krishna; T Bucky Jones; Theresa Currier Thomas
Journal:  Biomed Pharmacother       Date:  2021-08-27       Impact factor: 7.419

4.  Suppression of the insect cuticular microbiomes by a fungal defensin to facilitate parasite infection.

Authors:  Song Hong; Yanlei Sun; Haimin Chen; Chengshu Wang
Journal:  ISME J       Date:  2022-09-20       Impact factor: 11.217

5.  Microbiome assembly on Drosophila body surfaces benefits the flies to combat fungal infections.

Authors:  Song Hong; Yanlei Sun; Dapeng Sun; Chengshu Wang
Journal:  iScience       Date:  2022-05-14

6.  Preparation of Red Palm Weevil Rhynchophorus Ferrugineus (Olivier) (Coleoptera: Dryophthoridae) Germ-free Larvae for Host-gut Microbes Interaction Studies.

Authors:  Abrar Muhammad; Prosper Habineza; Youming Hou; Zhanghong Shi
Journal:  Bio Protoc       Date:  2019-12-20

7.  Novel Experimental Methods for the Investigation of Hermetia illucens (Diptera: Stratiomyidae) Larvae.

Authors:  Moritz Gold; Melanie Binggeli; Fabienne Kurt; Tomas de Wouters; Markus Reichlin; Christian Zurbrügg; Alexander Mathys; Michael Kreuzer
Journal:  J Insect Sci       Date:  2020-05-01       Impact factor: 1.857

8.  The Promoting Effect of Gut Microbiota on Growth and Development of Red Palm Weevil, Rhynchophorus ferrugineus (Olivier) (Coleoptera: Dryophthoridae) by Modulating Its Nutritional Metabolism.

Authors:  Prosper Habineza; Abrar Muhammad; Tianliang Ji; Rong Xiao; Xianyuan Yin; Youming Hou; Zhanghong Shi
Journal:  Front Microbiol       Date:  2019-05-29       Impact factor: 5.640

9.  M1-linked ubiquitination facilitates NF-κB activation and survival during sterile inflammation.

Authors:  Anna Aalto; Gabriela Martínez-Chacón; Christa Kietz; Nadezhda Tsyganova; Joose Kreutzer; Pasi Kallio; Meike Broemer; Annika Meinander
Journal:  FEBS J       Date:  2022-03-14       Impact factor: 5.622

Review 10.  The Microbiota and Gut-Related Disorders: Insights from Animal Models.

Authors:  Layla Kamareddine; Hoda Najjar; Muhammad Umar Sohail; Hadil Abdulkader; Maha Al-Asmakh
Journal:  Cells       Date:  2020-11-02       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.